The FDA’s big Gamble on the new Alzheimer’s Drug

The FDA’s big Gamble on the new Alzheimer’s Drug

By C. Michael White, The Conversation The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease via an accelerated approval pathway. This decision ignored the recommendation of the FDA’s external advisory panel to reject the drug. The FDA grants accelerated approvals for drugs to […]

Addressing Concerns on COVID-19 Youth Vax

Addressing Concerns on COVID-19 Youth Vax

By Linda Nwoke, Special to CAW Did you know that recent reports between March and April cited an increase in the hospitalization rates of teenagers aged 12 and above with Covid-19? This report made Rochelle Walensky, the Director of the Centers for Disease Control and Prevention, urge parents with eligible children to get them vaccinated […]